📰 Use Authorization News
Page 57 - Use Authorization News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Use Authorization. Real-time updates on events, politics, business and more.
April 13, 2021
Share this article Share this article SOUTH YARMOUTH, Mass., April 13, 2021 /PRNewswire/ -- Code 1 Supply, distributor of best-in-class medical diagnostics, brand-name supplies and equipment, and a leading provider of CPR training equipment and student materials, has announced the availability of AssureTechs EcoTest Covid-19 IgG/IgM Rapid Test Device for COVID-19 antibody detection for distribution. EcoTest is an in-vitro immunoassay for the direct and qualitative detection of anti-SARS-CoV- a...
April 13, 2021
A Newark pharmacy has paused administration of the Johnson & Johnson COVID-19 vaccine following recommendations from federal agencies.
April 12, 2021
Coronaviruses represent a large group of medically relevant viruses that were historically associated with the common cold. However, in recent years, members of
April 8, 2021
Some colleges confront political headwinds in adopting COVID vaccine mandates “I think we’re going to see legal challenges, because my sense is that this issue is very quickly becoming far less a legal issue or even a science and data and facts issue and it’s becoming a political issue,” said Peter McDonough, vice president and general counsel for the American Council on Education. ACE recently released an issue brief to aid college leaders in deciding whether to require or encourage va...
April 7, 2021
Author Bio Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. Follow @keithspeights Warren Buffett once said, "If you arent willing to own a stock for ten years, dont even think about owning it for ten minutes." To be quite candid, there are some popula...
April 7, 2021
Author Bio Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. Follow @keithspeights You can get rich quickly by buying shares of the right clinical-stage biotech. The problem is that you can also become poor quickly if you pick the wrong one. Thats why I think...
April 4, 2021
S&P 500 must increase its dividend for 50 consecutive years. AbbVie (NYSE:ABBV) is only one dividend hike away from moving into this highest echelon of dividend royalty. The big drugmaker has raised its dividend for 49 consecutive years, which qualifies AbbVie as a Dividend Aristocrat. Retirees should love AbbVies strong dividend track record. Theyll also really like its juicy dividend yield, currently at 4.8%. But AbbVie offers more than just a great dividend program: The company is set to de...
April 3, 2021
The U.S. new cases 7-day rolling average are 6.5 % HIGHER than the 7-day rolling average one week ago and U.S. deaths due to coronavirus are now 13.5 % LOWER than the rolling average one week ago. Todays posts include: U.S. Coronavirus New Cases are 68,844 U.S. Coronavirus deaths are at 961 U.S. Coronavirus immunizations have been administered to 47.1 % of the population The 7-day rolling average rate of growth of the pandemic shows new cases improved and deaths improved Just How Much Was 2020...
April 2, 2021
HEADLINES & GLOBAL NEWS By Apr 02, 2021 02:01 AM EDT A new study showed that Pfizers COVID-19 vaccine is 90 percent effective for at least six months and protects against the South African variant. Recent research emerged that the Pfizer-BioNTech COVID-19 vaccine is 90 percent effective for at least six months. It is the result of the study after the second dose, which was participated by over 46,000 persons in the clinical trial, in a published report in the USA Today. Effectivity of Pfize...
April 1, 2021
The BinaxNow professional test, which Abbott said is the same as the over-the-counter test, was launched in August 2020 and the North Chicago company has ramped up production to 50 million units a month. The U.S. Department of Health & Human Services purchased the companys first 150 million tests to sent to schools, nursing homes, historically black colleges and universities and underserved communities, the company statement said. "Weve now accomplished what we set out to do when we launched Bi...